Efficacy and Safety of Deep Brain Stimulation (DBS) of the Pallidal (GPi) in Patients With Tardive Dystonia

NCT00331669 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2009-03-04

No results posted yet for this study

Summary

The purpose of this randomized, double blind, multi-center study is to assess the efficacy and safety of bilateral pallidal deep brain stimulation in patients with tardive dystonia.

Conditions

  • Dystonia
  • Movement Disorder

Interventions

PROCEDURE

deep brain stimulation

high frequency stimulation

Sponsors & Collaborators

  • Humboldt-Universität zu Berlin

    collaborator OTHER
  • Ruhr University of Bochum

    collaborator OTHER
  • Medical University of Cologne

    collaborator OTHER
  • Heinrich-Heine University, Duesseldorf

    collaborator OTHER
  • University Hospital Freiburg

    collaborator OTHER
  • Medical University of Hannover

    collaborator OTHER
  • Medical University Innsbruck

    collaborator OTHER
  • University of Kiel

    collaborator OTHER
  • Philipps University Marburg

    collaborator OTHER
  • Ludwig-Maximilians - University of Munich

    collaborator OTHER
  • University of Rostock

    collaborator OTHER
  • University of Regensburg

    collaborator OTHER
  • University Hospital Tuebingen

    collaborator OTHER
  • Medical University of Vienna

    collaborator OTHER
  • Medtronic

    collaborator INDUSTRY
  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • Andreas R Kupsch, MD · Dpt. of Neurology, Augustenburger Platz 1, 13353 Berlin, Charite, Campus Virchow, Germany

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-05-31
Completion
2010-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00331669 on ClinicalTrials.gov